24 results
DEFM14A
ELYM
Eliem Therapeutics Inc
4 Jun 24
Proxy related to merger
8:00am
between Mr. Thomas and members of the Special Committee and Eliem’s nominating and corporate governance committee.
On March 24, 2024, representatives … to serve.
Andrew Levin, M.D., Ph.D. and Liam Ratcliffe, M.D., Ph.D. were recommended for election by the nominating and corporate governance committee
PREM14A
ELYM
Eliem Therapeutics Inc
17 May 24
Preliminary proxy related to merger
4:36pm
meetings between Mr. Thomas and members of the Special Committee and Eliem’s nominating and corporate governance committee.
On March 24, 2024 … will be unable to serve.
Andrew Levin, M.D., Ph.D. and Liam Ratcliffe, M.D., Ph.D. were recommended for election by the nominating and corporate governance committee
DEF 14A
c8tnh4prpwbqq 88u
8 Apr 22
Definitive proxy
4:20pm
10-K
hzbw00
7 Mar 22
Annual report
4:03pm
10-Q
f4i9d3eua
13 Sep 21
Quarterly report
4:01pm
424B4
v3yfoffiyc
11 Aug 21
Prospectus supplement with pricing info
5:05pm
S-1/A
etl95do7
2 Aug 21
IPO registration (amended)
6:08am
S-1/A
EX-10.4
6vq77cx3 6nr8qxpnn
2 Aug 21
IPO registration (amended)
6:08am